JUPITER STUDY HIGHLIGHTS 4 REASONS TO SAY NO TO CRESTOR
Shane Ellison M. Sc.
The People's Chemist
December 7, 2008
There's been a deep lying suspicion that a deliberate push to get each and every American hooked on drugs, while at the same time bankrupting them, exists among Big Pharma, the U.S. government and the popular media. But now, a new study confirms this suspicion as fact. It's the JUPITER study.
JUPITER stands for Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin. It's not a clinical trial. It's a rouse to promote drugs as vitamins. Dr. Timothy J. Gardner, president of the American Heart Association, was so excited by it that he insisted, "this one [JUPITER] is pretty clearly a winner for statin therapy."
The New York Times gave us the infomercial, scripted response of, "Taking the statin Crestor, also known as rosuvastatin, slashed the risk of heart attack by more than half according to the JUPITER results." But if you believe this, then you're already on too many drugs.
Big Pharma money can be intoxicating. Like a frat boy with beer goggles, few health professionals or popular media outlets could see the ugly truth. Four important points of the JUPITER rouse were missed, which serve as four reasons to avoid Crestor.
The media failed to mention that Crestor makers - AstraZeneca - funded the study. When a company pays for a study, they pay for the interpretation of results, which always involves statistical trickery. Most of us learned this with the heart attack inducing, pain killer Vioxx. Touted as the safest NSAID of all time, it proved to be the deadliest once unleashed with the rubber stamp approval of the Food and Drug Administration (FDA) - it snuffed out an estimated 40,000 lives, fast. Its' wake of destruction still resonates within Americans, but apparently not with the media.
The media failed to mention the statistical trickery at work. Cardiovascular events were reduced by an absolute, paltry 0.9% with Crestor use. Using a few tricks of the statistics trade, this bland number was converted into the more lucrative, "relative risk reduction" of 53%. This trickery happens so fast, it's like watching magician David Blaine pull his heart out of his chest. You don't know if it's real or just a cheap magic trick. Dr. Mark Hlatky of Stanford shows that it's just a trick.
Commenting on the trickery, he told the New England Journal of Medicine that, "absolute differences in risk are more clinically important than relative reductions in risk in deciding whether to recommend drug therapy, since the absolute benefits of treatment must be large enough to justify the associated risks and costs." But, using statistical sleight of hand helps AstraZeneca make some serious cash.
The media failed to mention that it would cost bookoo bucks to follow JUPITER's recommended Crestor protocol. The drug giant stands to pocket an estimated $500,000 per patient, courtesy of their insurance company, if the drug is used as recommended by the study - over a patient's lifetime.
And finally, the media failed to mention that Crestor users risk the particularly, nasty side effect of liver failure, rhabdomyolysis, diabetes and more. If you really needed another one, that's the fourth reason to say no to Crestor: It's a seriously expensive way to get sick.
Subscribe to the NewsWithViews Daily News Alerts!
Falsely promoting ineffective and dangerous drugs, while pillaging bank accounts, is illegal. Street thugs go to jail every day for it. If the JUPITER rouse is to be condoned by the federal government and supported by the media, then there is no need for the FDA since Big Pharma can violate the laws with predatory prescription hype disguised as science. Say no to Crestor and all the other cholesterol-lowering drugs. Otherwise, face the outcomes of government mandated drug addiction.
Ellison's entire career has been dedicated to the study of molecules; how they give life and how they take from it. He was a two-time recipient of the prestigious Howard Hughes Medical Institute Research Grant for his research in biochemistry and physiology. He is a bestselling author, holds a master's degree in organic chemistry and has first-hand experience in drug design. Use his knowledge and insight to look and feel your best in 90 days with his AM-PM Fat Loss Discovery. Click here to read more.
� 2008 Shane Ellison - All Rights Reserve